Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Presentation: Metabolomics for discovering the functions of genes with embryonic-lethal mutations (Agilent)

7 Oct 2014
General interest

Presentation held by Steven S. Gross, Department of Pharmacology Weill Cornell Medical College (NY, NY).

sgross

 

Click here to view presentation.

Related Links

  • Agilent Technologies

 

Top content

  • A pivotal peril of profoundly pernickety peptides
  • An author’s perspective: Shuanglin Qin on advancing oligonucleotide-based PROTACs for undruggable therapeutic targets
  • Mastering bioanalytical project management

Related tags

metabolomics
Previous article Next article

Related articles

3 OCT 2016 REGULATED BIOANALYSIS
A simple, effective approach for rapid development of high-throughput and reliable LC–MS/MS bioanalytical assays
28 JUN 2011 CHROMATOGRAPHY
In vivo solid-phase microextraction sampling: a promising future
11 JUL 2017 NEWS
Thermo Fisher Scientific announces collaboration with SRI International to advance small molecule research
6 JUL 2020 GENERAL INTEREST
The latest metabolomics developments: an interview with Martin Giera
28 FEB 2025 NEWS
Uncovering the metabolic clues of preeclampsia
17 JUN 2015 DATA PROCESSING AND INTERPRETATION
Optimizing artificial neural network models for metabolomics and systems biology: an example using HPLC retention index data
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone